AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Epimmune provides HIV vaccine program update.(Brief Article)
2002 MAR 6 - (NewsRx.com & NewsRx.net) -- Epimmune Inc., (EPMN) provided an update on the status of its initial HIV vaccine candidate including clinical trial plans.
The company stated that, as additional time is necessary to complete all of the animal safety studies that were contemplated in its pre-IND discussions with the U.S. Food and Drug Administration, it anticipates filing an Investigational New Drug (IND) application for its initial vaccine candidate, a therapeutic HIV vaccine, during the second quarter of 2002. Clinical trials could begin approximately 1 month after filing the IND, pending FDA review.
The initial clinical trials, supported by an NIH grant which was recently increased by approximately $500,000, will be conducted at the University of Colorado Health Services Center under the direction of Constance Benson, MD, and Cara Wilson, MD, and will involve approximately 40 infected individuals on HAART therapy. Endpoints of the initial Phase I/II trial will be safety and immunogenicity.
"We continue to believe that our HIV vaccine approach is on the right track," said Mark Newman, PhD, Epimmune. "Epimmune studies, as well as recent results by others ...
- GenVec and NIH Move HIV Vaccine Candidate Into Human Clinical Trials.
- Press release article from: PR Newswire July 28, 2004 700+ words
...clinical study to test an HIV vaccine candidate developed utilizing GenVec...NIAID and will employ HIV vaccine candidates produced by...advancement in the field of HIV vaccine development. This unique vaccine candidate is being developed for...
- Chiron's HIV Vaccine Candidate Begins Clinical Trial in United States; Trial...
- Press release article from: PR Newswire January 15, 2004 700+ words
...United States for its HIV vaccine candidate. The trial, the result...collaboration between the HIV Vaccine Trials Network (HVTN...vaccine. "Chiron's vaccine candidate represents a novel approach to HIV vaccine development, and we...
- IAVI Begins First Phase II Preventive HIV Vaccine Trial in South Africa to Test...
- Press release article from: Business Wire November 14, 2005 700+ words
...tgAAC09, a preventive HIV vaccine candidate that is based on...the first Phase II HIV vaccine trial to be held...approved its first HIV vaccine trials in 2003...of this promising vaccine candidate while supporting...
- IAVI begins first Phase II preventive HIV vaccine trial in South Africa to test...
- News wire article from: Chemical Business Newsbase November 14, 2005 700+ words
...tgAAC09, a preventive HIV vaccine candidate that is based on...the first Phase II HIV vaccine trial to be held...approved its first HIV vaccine trials in 2003...HIV vaccines. The vaccine candidate, tgAAC09, utilizes...
- Epimmune's HIV Vaccine Candidate Taken by the National Institutes of Health and...
- Press release article from: PR Newswire April 7, 2003 700+ words
...ideal setting to evaluate our HIV vaccine candidate." "The HVTN welcomes the...speeding progress toward an HIV vaccine and controlling the global pandemic...inventors." The EP HIV-1090 vaccine candidate is composed of DNA that has...
- GENEART Supports the UK HIV Vaccine Consortium (UK HVC) in Developing a DNA...
- News wire article from: Europe Intelligence Wire June 19, 2009 700+ words
...San Francisco (USA) employ more than 190 people. GENEART is listed on the German Stock Exchange. About the UK HVC The UK HIV Vaccine Consortium is an integrated and project-managed collaboration between Imperial College London, St George's University...
- Geneart AG supports the UK HIV Vaccine Consortium (UK HVC) in developing a DNA...
- News wire article from: Chemical Business Newsbase June 19, 2009 700+ words
...Geneart AG announced being awarded a contract for the design and production of two DNA vaccine candidates against HIV by the UK HIV Vaccine Consortium (HVC). The genes (blueprints for virus proteins), optimised and customised by Geneart, are to be used as...
- Epimmune's HIV vaccine candidate taken by the National Institutes of Health and...
- News wire article from: Asia Africa Intelligence Wire April 7, 2003 700+ words
...multi-site, Phase I trial was recently initiated by the HIV Vaccine Trials Network (HVTN), which is conducting the trial...determine the safety of the vaccine. The EP HIV-1090 vaccine candidate is composed of DNA that has been synthetically produced...
- Chiron's HIV vaccine candidate begins clinical trial in US.
- News wire article from: Asia Africa Intelligence Wire January 15, 2004 700+ words
...clinical trial in the US for its HIV vaccine candidate. The trial, the result of a collaboration between the HIV Vaccine Trials Network (HVTN), funded...immunogenicity of the vaccine. The vaccine candidate employs a strategy that involves...
- Epimmune's Recombinant Protein HIV Vaccine Candidate to be Tested in Clinical...
- Press release article from: PR Newswire July 26, 2005 700+ words
...infection. The vaccine candidate will be evaluated...conducted by the HIV Vaccine Trials Network...multi-epitope DNA vaccine candidate, will be investigated...epitopes into a single vaccine candidate, the immune response...
Source: HighBeam Research, Epimmune provides HIV vaccine program update.(Brief Article)